Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
08/2006
08/03/2006US20060172928 providing a biomolecule such as nucleic acid, protein, antibody immobilized on a substrate (quartz, glass etc) covering with a nonreducing disaccharide trehalose or sucrose; a protein or peptide of Late Embryogenesis Abundant (LEA) class comprising a motif of 11 amino acids; biochip; storage stability
08/03/2006US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection
08/03/2006US20060172310 Detection and quantification process for more than one nucleic acid in library
08/03/2006US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
08/03/2006US20060171961 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations
08/02/2006EP1685245A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
08/02/2006CN1810837A Synthesis of proteins by native chemical ligation
08/02/2006CN1810836A Human proinsulin-KGD chimeric peptide as new recombinat antithrombotic with thrombocyte GP-IIb-IIIa receptor specificity
08/02/2006CN1267449C Methods and compositions for peptide synthesis
08/01/2006US7084258 Antibodies against the PRO862 polypeptides
08/01/2006US7084254 Ti-4 protein derived from Triatoma infestans exhibiting activity to inhibit platelet aggregation
08/01/2006US7084118 Combination treatment with t-PA variant and low molecular weight heparin
08/01/2006CA2193867C Hydrophobic chromatographic resins with ionizable groups
08/01/2006CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof
07/2006
07/27/2006WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto
07/27/2006WO2004091517A3 Conjugates comprising human il-18 and substitution mutants thereof
07/27/2006WO2004039948A3 Actriib fusion polypeptides and uses therefor
07/27/2006WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof
07/27/2006US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/27/2006US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes
07/27/2006US20060166213 Novel compositions and methods in cancer
07/27/2006US20060165730 Polysaccharide and glycoconjugate vaccines
07/26/2006EP1682866A2 Gel-shell beads with adsorbed or bound biomolecules
07/26/2006EP1682655A1 Carbohydrate-binding modules of a new family
07/26/2006EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
07/26/2006CN1265840C Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5
07/25/2006US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/25/2006US7081517 Nucleotide sequences coding for use in detection of mamary gland cancer
07/20/2006WO2005120700A3 Peptide purification by means of hard metal ion affinity chromatography
07/20/2006US20060160246 Graphitic nanotubes in luminescence assays
07/20/2006CA2594318A1 Irta-2 antibodies and their uses
07/19/2006EP1681303A1 HASylated polypeptides, especially HASylated erythropoietin
07/19/2006EP0988314B1 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
07/19/2006CN1803845A Method for preparing carbon nanotube-protein stationary phase
07/19/2006CN1264860C Method for surface display of proteins on genetic carriers
07/18/2006US7078496 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
07/18/2006US7078482 An isolated protein of homology between the amino acid sequence ID NO: 1 and 2 and known amino acid sequences of other proteins such as human eosinophil granule major basic protein; anticarcinogenic0, -tumor and -inflammatory agents; leukemia; viricides; wound healing agents; parasiticides; immunology
07/18/2006US7078197 Peptide acceptor ligation methods
07/18/2006US7078192 Method for immobilization of polypeptides
07/18/2006US7078042 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
07/18/2006US7078021 Dental products comprising bone growth enhancing peptide
07/18/2006CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof
07/13/2006WO2006072140A1 Detecting molecules
07/13/2006US20060153922 Light induced immobilisation
07/12/2006CN1800238A Aliphatic polyester-polyamino acids copolymer with biological function and its synthesis method
07/12/2006CN1263852C Extracellular matrix signalling molecules
07/12/2006CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof
07/11/2006US7074910 PRO4340 nucleic acids
07/11/2006US7074904 MHC molecule that contains a peptide-binding groove, and a presenting peptide covalently linked to the MHC molecule, the fusion complex being capable of modulating the activity of a T cell.
07/11/2006US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography
07/11/2006US7074615 Peptides for enhanced cell attachment and cell growth
07/11/2006US7074560 Purification of tissue plasminogen activator (tPA)
07/11/2006US7074397 Method for enhancing proliferation or differentiation of a cell using ob protein
07/11/2006CA2207282C Functionalized nanotubes
07/06/2006WO2006071132A1 Biological microchip for multiple parallel immunoassay of compounds and immunoassay methods using said microchip
07/06/2006WO2005116081A3 Stable protein storage and stable nucleic acid storage in recoverable form
07/06/2006WO2004112565A3 Diagnosis and treatment of liver, pulmonary and cardiac fibrosis
07/06/2006US20060149039 Pseudo-native chemical ligation
07/06/2006US20060149032 Recombinant hepatitis B surface antigen
07/06/2006US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders
07/06/2006US20060147914 evaluating ability of agents to modulate Homer protein activity, Homer protein/immunophilin-peptidylproline cis-trans isomerase interaction, and/or Homer protein/proline-type Homer ligand consensus sequence interaction to identify agents for treatment; modulation of immunosupression and neuroprotection
07/05/2006EP1210373B1 Congener independent detection of microcystin and nodularin congeners
07/05/2006EP1107979B1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
07/05/2006CN1798766A Humanized antibodies that recognize beta amyloid peptide
07/04/2006US7071296 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology
07/04/2006US7071293 Protein; biological antigrowth agent; bactericides
07/04/2006US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections
06/2006
06/29/2006US20060141597 Valency platform molecules comprising aminooxy groups
06/29/2006US20060141548 Immunoassays for everolimus
06/28/2006EP1673633A1 Method and device for detecting feline immunodeficiency virus
06/28/2006EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy
06/27/2006US7067639 Method to provide bacterial ghosts provided with antigens
06/27/2006US7067633 mutant dynein light chain-1/protein inhibitor of nitric oxide synthase polypeptide; comprises a DLC1/PIN polypeptide lacking serine 88 of DLC1/PIN, a DLC1/PIN polypeptide lacking the C-terminal 19 amino acids of DLC1/PIN, and/or a DLC1/PIN polypeptide lacking the C-terminal 23 amino acids of DLC1/PIN
06/27/2006US7067625 Isolated TWIK-1 potassium channel proteins
06/27/2006US7067618 reaction product of a peptide (e.g., an insulin or enkephalin) with a lactose or sialyllactose reducing sugar and optionally reacting the product with polyoxyethylene, polyglutamic acid or polyvinylpyrrolidone; peptide is released in response to pH change; improved in vivo durability of targeted drugs
06/27/2006US7067473 Human neurotrophic polypeptide containing an amino acid sequence of 113 amino acids
06/27/2006US7067326 Binding particle for use in the biosynthesis and separation of particles in sample
06/27/2006US7067267 Method of assaying pyrrole-containing biological compounds
06/22/2006WO2006066065A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv
06/22/2006US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4
06/21/2006EP1670829A1 Attachment of cells to surfaces
06/21/2006EP0912198B1 Immunoliposomes that optimize internalization into target cells
06/21/2006CN1791644A Method of enhancing fluorescence
06/20/2006US7064185 Antibody for human Cyr61
06/20/2006US7064179 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions
06/20/2006CA2489105A1 Development of a method for employing polystyrene/dextran nabo-particles in immunoassay
06/20/2006CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof
06/15/2006WO2005105910A3 Water-soluble, uv-absorbing and/or fluorescent components with very high isoelectric points
06/15/2006US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity
06/14/2006EP1379650B1 Preferred segments of neural thread protein and methods of using the same
06/14/2006EP0934072B1 Manufacturing process for the production of purified transferrin
06/14/2006EP0639276B1 Factorial chemical libraries
06/13/2006US7060804 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
06/08/2006WO2006023831A3 Sequential protein isolation and purification schemes by affinity chromatography
06/08/2006WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease
06/08/2006US20060122368 Antigen delivery platform
06/08/2006US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
06/08/2006US20060121021 by which blood cells can be stimulated; amount of required mAbs is lower than when using the same mAbs in a solution, which makes the stimulation independent from the presence or the quality of non-T cells carrying Fc-receptors, and which can be prepared in an easier way under GMP conditions
06/08/2006DE10322414B4 Bindung von Proteinen in nativem Zustand an ein Substrat Binding of proteins in the native state to a substrate
06/08/2006DE10081928B4 6-O-Acetylmorphin (6MAM)-Analoge Verbindungen, welche zur Verwendung in Immuntests geeignet sind, hiergegen gewonnene Antikörper, deren Herstellung sowie Reagentien und Reagenssysteme, die diese umfassen 6-O-acetylmorphine (6MAM) analogs compounds which are suitable for use in immunoassays, antibody obtained against this, their preparation as well as reagents and reagent systems which comprise these
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 107